Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?

European Journal of Clinical Pharmacology

Volumn 66, Issue 3, 2010, Pages 261-267

  Khalili, Hossein ^a   Dashti Khavidaki, Simin ^a   Amini, Mohsen ^a   Mahjub, Reza ^a   Hajiabdolbaghi, Mahboobeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylation; Isoniazid; Phenotype; Tuberculosis

Indexed keywords

ACETYLISONIAZID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; DRUG DERIVATIVE; TUBERCULOSTATIC AGENT;

ACETYLATOR PHENOTYPE; ADULT; ARTICLE; BACTERIUM CULTURE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG ACETYLATION; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; TUBERCULOSIS; ACETYLATION; ADOLESCENT; BIOTRANSFORMATION; BLOOD; METABOLISM; MIDDLE AGED; PHENOTYPE;

ACETYLATION; ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BIOTRANSFORMATION; CASE-CONTROL STUDIES; FEMALE; HUMANS; IRAN; ISONIAZID; MALE; MIDDLE AGED; PHENOTYPE; TUBERCULOSIS; YOUNG ADULT;

EID: 77951927293     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0745-1     Document Type: Article

References (33)

1. Schaaf HS, Parkin DP, Seifart HI, Werely CJ, Hesseling PB, van Helden PD, Maritz JS, Donald PR (2005) INH pharmacokinetic in children treated for respiratory tuberculosis. Arch Dis Child 90:614-618
2. Weber WW, Hein DW (1979) Clinical pharmacokinetics of INH. Clin Pharmacokinet 4:401-422
3. The American Pharmacists Association (APhA) (2006) Drug information handbook international, 14th edn. Lexi-Comp, The American Pharmacists Association (APhA), Hudson, OH, pp 936-938
4. Meyer UA, Zanger UM, Skoda RC, Grant D, Blum M (1990) Genetic polymorphism of drug metabolism. Progress in liver diseases. Prog Liver Dis 9:307-323
5. Evans DA, Manley KA, McKusick VA (1960) Genetic control of INH metabolism in man. Br Med J 2:485-491
6. Schoeman JF, Morkel A, Seifart HI, Parkin DP, Van Helden PD, Hewlett RH, Donald PR (1998) Massive posterior fossa tuberculous abscess developing in a young child treated for miliary tuberculosis. Possible role of very rapid acetylation of INH. Pediatr Neurosurg 29:64-68
7. The American Society of Health-System Pharmacists (AHFS). Drug Information 2007:554-559
8. Possuelo LG, Castelan JA, de Brito TC, Ribeiro AW, Cafrune PI, Picon PD, Santos AR, Teixeira RL, Gregianini TS, Hutz MH, Rossetti ML, Zaha A (2008) Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol 64:673-678
9. Steichen O, Martinez-Almoyna L, De Broucker T (2006) Isoniazid induced neuropathy: consider prevention. RevMal Respir 23:157-160
10. Meyer UA, Zanger UM (1997) Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 37:269-296
11. Sunahara S, Uren M, Agawa M (1961) Genetic and geographical studies on INH inactivation. Science 134:1530-1531
12. Seifart HI, Parkin DP, Botha FJ, Donald PR, Van Der Walt BJ (2001) Population screening for INH acetylator phenotype. Pharmacoepidemiol Drug Saf 10:127-134
13. World Health Organization Global Tuberculosis Programme (2003) Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.13, 3rd edn. WHO, Geneva
14. Wilcke JT, Døssing M, Angelo HR, Askgaard D, Rønn A, Christensen HR (2004) Unchanged acetylation of INH by alcohol intake. Int J Tuberc Lung Dis 8:1373-1376
15. FoxHH, Gibas JT (1953) Synthetic tuberculostat. Acyl derivatives of isonicotinyl hydrazine. J Org Chem 18:1375-1379
16. Fox HH, Gibas JT (1953) Synthetic tuberculostat. Alkidenyl derivatives of isonicotinyl hydrazine. J Org Chem 18:983-989
17. Fox HH, Gibas T (1953) Synthetic tuberculostat. Mono-alkyl derivatives of isonicotinyl hydrazine. J Org Chem 18:994-1002
18. Hutchings A, Monie RD, Spragg B, Routledge PA (1983) High performance liquid chromatographic analysis of INH and acetylINH in biological fluids. J Chromatogr 277:385-390
19. Hutchings A, Routledge PA (1986) A simplemethod for determining acetylator phenotype using INH. Br J Clin Pharmacol 22:343-345
20. Miscoria G, Leneveu A, Walle C, Roux A (1988) Application of a method of analysis using high performance liquid chromatography of INH and acetylINH to determine the phenotype of acetylation. Ann Biol Clin 46:734-740
21. Kohno H, Kubo H, Takada A, Mori M, Arias TD (1996) INH acetylation phenotyping in the Japanese: the molar metabolic ratio INH/AcINH. Am J Ther 3:74-78
22. Gupta RC, Nair CR, Jindal SK, Malik SK (1984) Incidence of INH acetylation phenotype in North Indians. Int J Clin Pharmacol Ther Toxicol 22:259-264
23. Matar KM, Mayet AY, Ayoola EA, Bawazir SA, Al-Faleh FZ, Al-Wazzan A (2004) INH acetylation in Saudi Arabs. J Clin Pharm Ther 29:443-447
24. Irshaid YM, Al-Hadidi HF, Abuirjeie MA, Rawashdeh NM (1991) N-acetylation phenotyping using dapsone in a Jordanian population. Br J Clin Pharmacol 32:289-293
25. Sohrani AS, Ahmad B, Janbaz KH (1995) Acetylation percentage method for determination of acetylator status in human volunteers and tuberculosis patients. Pak J Pharma Sci 8:11-16
26. Kita T, Tanigawara Y, Chikazawa S, Hatanaka H, Sakaeda T, Komada F, Iwakawa S, Okumura K (2001) N-acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients. Biol Pharm Bull 24:544-549
27. Hassanzadeh MK, Khashayarmanesh Z (1999) N-acetylation phenotyping using INH in an Iranian and an Afghani population. Indian J Pharm Sci 61:297-300
28. Bakayev VV, Mohamadi F, Javeri A, MasjediMR, Velayati AA (2004) Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals. Eur J Clin Pharmacol 60:467-471
29. O'Neil WM, Drobitch RK, MacArthur RD, Farrough MJ, Doll MA, Fretland AJ, Hein DW, Crane LR, Svensson CK (2000) Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype. Pharmacogenetics 10:171-182
30. Singh N, Dubey S, Chinnaraj S, Golani A, Maitra A (2009) Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients. Mol Diagn Ther 13:49-58
31. Torkaman-Boutorabi A, Hoormand M, Naghdi N, Bakhshayesh M, Milami I (2007) Genotyping and allele frequencies of Nacetyltransferase 2 and glutathione S-transferase in the Iranian population. Clin Exp Pharmacol Physiol 34:1207-1211
32. Küpeli E, Karnak D, Beder S, Kayacan O, Tutkak H (2008) Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smearnegative pulmonary tuberculosis patients. Respiration 75:73-78
33. Drobitch RK, Tomilo M, Svensson CK (1992) Immunomodulation and drug acetylation: influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content. Biochem Pharmacol 43:1643-1648